When the Inflation Reduction Act passed the Senate Sunday, Republicans successfully blocked a price cap on insulin. Robert Weissman, president of Public Citizen, says that despite its flaws, the bill is a win against the pharmaceutical industry’s exploitative profits. “They’re super worried that this is a break in the dam and that it will lead to more negotiation, once we, the American people, see plainly the cost savings that are available,” says Weissman. Democracy Now! is an independent global news hour that airs on over 1,500 TV and radio stations Monday through Friday. Watch our livestream at https://democracynow.org Mondays to Fridays 8-9 a.m. ET. Support independent media: https://democracynow.org/donate Subscribe to our Daily Email Digest: https://democracynow.org/subscribe #DemocracyNow